Astera实验室的经理在获得丰厚收入和提升指导后出售了13.85M美元股票。 Executives sold $13.85M in Astera Labs stock after strong earnings and raised guidance.

2026年2月17日, 包括CFO Michael Truett Tate、CO OO Sanjay Gajendra和总法律顾问Philip Mazzara在内的Astera实验室执行官共出售111 821股股票,平均价为123.80至123.81美元,共计约1 385万美元。 On February 17, 2026, Astera Labs executives including CFO Michael Truett Tate, COO Sanjay Gajendra, and General Counsel Philip Mazzara sold a combined 111,821 shares at an average price of $123.80–$123.81, totaling approximately $13.85 million. 销售量将其直接所有权减少了3.39%,减至5.88%。 The sales reduced their direct ownership by 3.39% to 5.88%. 该公司在2月10日报告2025年的Q4收入丰厚,有58 000 EPS和2.7558亿美元的收入,比上一年增长91.8%,并提出了2026年的Q1指南。 The company reported strong Q4 2025 earnings on February 10, with $0.58 EPS and $270.58 million in revenue, up 91.8% year-over-year, and raised Q1 2026 guidance. 2月20日的股票交易额为132.62美元,市场上限为224亿美元,“机动买家”分析师的共识评级为“Moderate Buy”。 The stock traded at $132.62 on February 20, with a market cap of $22.4 billion and a "Moderate Buy" analyst consensus rating.